A Phase 2, Multi-Cohort, Open-Label Study of Intratumoral Tavokinogene Telseplasmid Plus Electroporation in Combination with Intravenous Pembrolizumab Therapy with or without Chemotherapy in Patients with Inoperable Locally Advanced or Metastatic Triple Negative Breast Cancer